Causal influences of neuropsychiatric disorders on Alzheimer’s disease

Causal influences of neuropsychiatric disorders on Alzheimer’s disease

Abstract Previous studies have observed a significant comorbidity between Alzheimer’s disease (AD) and some other neuropsychiatric disorders. However, the mechanistic connections between neuropsychiatric disorders and AD are not well understood. We conducted a Mendelian randomization analysis to app...

Full description

Bibliographic Details
Main Authors:	Ancha Baranova, Qian Zhao, Hongbao Cao, Vikas Chandhoke, Fuquan Zhang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-02-01
Series:	Translational Psychiatry
Online Access:	https://doi.org/10.1038/s41398-024-02822-1

Similar Items

Shared genetics and bidirectional causal relationships between type 2 diabetes and attention-deficit/hyperactivity disorder
by: Fuquan Zhang, et al.
Published: (2023-03-01)

Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases
by: Fuquan Zhang, et al.
Published: (2021-11-01)

Causal influences of osteoarthritis on COVID-19: a Mendelian randomization study
by: Li Fu, et al.
Published: (2023-10-01)

Causal associations between COVID-19 and childhood mental disorders
by: Fei Chen, et al.
Published: (2023-12-01)

Exploring the influences of education, intelligence and income on mental disorders
by: Fuquan Zhang, et al.
Published: (2024-02-01)

Causal Association and Shared Genetics Between Asthma and COVID-19
by: Ancha Baranova, et al.
Published: (2022-03-01)

Bidirectional associations between mental disorders, antidepressants and cardiovascular disease
by: Qian Zhao, et al.
Published: (2024-05-01)

Causal Associations between Posttraumatic Stress Disorder and COVID-19
by: Ancha Baranova, et al.
Published: (2024-04-01)

Causal associations between posttraumatic stress disorder and type 2 diabetes
by: Yuqing Song, et al.
Published: (2025-02-01)

Shared Genetic Liability Between Major Depressive Disorder and Atopic Diseases
by: Hongbao Cao, et al.
Published: (2021-09-01)

Mendelian randomization analysis of causal and druggable circulating inflammatory proteins in schizophrenia
by: Hongbao Cao, et al.
Published: (2024-10-01)

Phenome-wide investigation of bidirectional causal relationships between major depressive disorder and common human diseases
by: Wenxi Sun, et al.
Published: (2024-12-01)

Gut microbiome and major depressive disorder: insights from two-sample Mendelian randomization
by: Qian Zhao, et al.
Published: (2024-07-01)

Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses
by: Ancha Baranova, et al.
Published: (2021-09-01)

Causal effects of education, intelligence, and income on COVID-19: evidence from a Mendelian randomization study
by: Yuqing Song, et al.
Published: (2025-02-01)

Gut microbiome’s causal role in head and neck cancer: findings from mendelian randomization
by: Meng Lian, et al.
Published: (2024-11-01)

Causal associations of tea intake with COVID-19 infection and severity
by: Ancha Baranova, et al.
Published: (2023-01-01)

Preeclampsia Drives Molecular Networks to Shift Toward Greater Vulnerability to the Development of Autism Spectrum Disorder
by: Qinglian Xie, et al.
Published: (2020-07-01)

The causal relationship between immune cell traits and schizophrenia: a Mendelian randomization analysis
by: Jianbin Du, et al.
Published: (2024-09-01)

Reply Regarding “Correlation Between Post-traumatic Stress Disorder and SARS-CoV-2 Infection”
by: Ancha Baranova, et al.
Published: (2025-02-01)

TNFRSF12A and CD38 Contribute to a Vicious Circle for Chronic Obstructive Pulmonary Disease by Engaging Senescence Pathways
by: Yan Dong, et al.
Published: (2020-05-01)

In silico Gene Set and Pathway Enrichment Analyses Highlight Involvement of Ion Transport in Cholinergic Pathways in Autism: Rationale for Nutritional Intervention
by: Audrey Olson, et al.
Published: (2021-04-01)

miRNA-Coordinated Schizophrenia Risk Network Cross-Talk With Cardiovascular Repair and Opposed Gliomagenesis
by: Hongbao Cao, et al.
Published: (2020-03-01)

Neuropsychiatric disorders correction in Alzheimer's disease
by: N. N. Koberskaya
Published: (2022-06-01)

In a search of a protective titer: Do we or do we not need to know?
by: Ancha Baranova, et al.
Published: (2021-12-01)

Gut microbiome and schizophrenia: insights from two-sample Mendelian randomization
by: Keer Zhou, et al.
Published: (2024-09-01)

Treatment of noncognitive neuropsychiatric disorders in Alzheimer's disease
by: A. B. Lokshina, et al.
Published: (2021-12-01)

Shared genetic liability between major depressive disorder and osteoarthritis
by: Fuquan Zhang, et al.
Published: (2022-01-01)

Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer’s Disease
by: Jiming Chen, et al.
Published: (2025-01-01)

Neuropsychiatric symptoms in Alzheimer’s disease
by: J. Vegytė, et al.
Published: (2024-02-01)

The influence of neuropsychiatric and functional changes on quality of life in Alzheimer's disease
by: Marcia M.P.C. Novelli, et al.

The neural basis of neuropsychiatric symptoms in Alzheimer’s disease
by: Nicole K. Zhang, et al.
Published: (2024-12-01)

Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer's Disease and Related Disorders
by: Emmanuel Mulin, et al.
Published: (2010-07-01)

Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
by: E. G. Mendelevich
Published: (2018-11-01)

Causal relationships between neuropsychiatric disorders and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study
by: Shisong Wang, et al.
Published: (2024-09-01)

Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
by: Grace J. Goodwin, et al.
Published: (2023-08-01)

Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
by: Behnam Iravani, et al.
Published: (2022-07-01)

Big Data Analysis of Genes Associated With Neuropsychiatric Disorders in an Alzheimer’s Disease Animal Model
by: Suji Ham, et al.
Published: (2018-06-01)

Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19
by: Ancha Baranova, et al.
Published: (2024-02-01)

BDNF Gene's Role in Schizophrenia: From Risk Allele to Methylation Implications
by: Xiaoqian Fu, et al.
Published: (2020-12-01)